Mary Meeker, tech maven and founder of the newly formed Bond Capital -- and former partner at venture-capital firm Kleiner Perkins Caufield & Byers -- recently presented her latest internet trends report at Recode’s Code 2019 conference, and this one was nearly as large as the 2017 presentation. This recap highlights what’s relevant for pharma marketers.
Facebook will soon roll out a new tool called Clear History that would give users the option to disassociate their online activity from their Facebook profiles, essentially erasing their personal digital footprints. Marketers can’t afford to mute this conversation.
Intouch and Veeva collaborated to provide a dive deep into best practices and actionable tips for understanding artificial intelligence and machine learning, setting the stage for successful integration of AI and ML into your marketing strategy, and applying AI in key areas for life sciences organizations.
Kick back with the television, a magazine, or some quality YouTube time, and you’re likely to see diversity and inclusion in many ads. Ideally, you’ll see differently abled people, interracial couples with biracial children, active seniors, same-sex couples, people of short stature, full-figured models, and friend groups that resemble the
Earlier this year, we pondered whether voice search is simply a fad or whether it’s a trend we can’t go backward from, particularly as more and more people rely on their smart phones and speakers for answers to pressing questions. Our conclusion? “From basic accessibility to on-demand disease education and
At the Coalition’s Rising Leaders conference on healthcare policy in Washington, D.C. May 22, a diverse set of speakers provided updates and predictions, and discussed the potential impact of the many significant healthcare policy decisions pending on Capitol Hill. This POV provides an overview of five issues to watch that were highlighted at the conference, as well as strategies for addressing them.
Planners. What are we, anyway? Often, our roles get summed up pretty briefly. We’re the strategists. Or, we’re the researchers. Or the ones creating the customer journeys. And while that’s true, what we do is a lot more than that. I love that planning is made up of so many
In the wake of the May 8 list-price mandate for DTC TV ads issued by the Centers for Medicare & Medicaid Services (CMS) -- and, even before that, since the draft rule was issued in October 2018 -- one of the questions we are hearing from clients is, “What about YouTube?” Read on to learn more.
With the advancement of programmatic media in the pharmaceutical space, many types of targeting are available that can identify and serve pharma ads to the right audiences, both in direct-to-consumer (DTC) and healthcare provider (HCP) advertising. When putting together a media plan for a specific brand, it is important to consider the disease state sensitivity associated with the brand before aligning on targeting tactics.
On May 8, 2019, the Trump administration announced that the Centers for Medicare & Medicaid Services (CMS) would require drugs covered by Medicare or Medicaid to include a list price in any DTC television commercial within 60 days of the announcement, if their list price is at least $35 for a month’s supply or a course of treatment. The ruling is virtually the same as the one proposed in October 2018, and only products that advertise on TV are affected directly by the ruling. This POV provides a brief summary of the background to this ruling, a summary of its specifics, some reactions to it, and our recommendations to clients in its wake.